Close Menu

NEW YORK – Thermo Fisher Scientific and First Genetics said on Monday that they are collaborating to commercialize next-gen sequencing-based diagnostics in Russia.

Under the strategic partnership, First Genetics, a Russian manufacturer of diagnostic equipment and IVD kits, will market its F-Genetics NGS System and IVD assays to Russian laboratories for reproductive health testing and cancer diagnostics. The F-Genetics system is based on Thermo Fisher's Ion GeneStudio S5 sequencer.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.